APA (7th ed.) Citation

Röder, F., Timke, C., Saleh-Ebrahimi, L., Schneider, L., Hackert, T., Hartwig, W., . . . Werner, J. (2012). Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC cancer, 12, . https://doi.org/10.1186/1471-2407-12-112

Chicago Style (17th ed.) Citation

Röder, Falk, et al. "Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-modulated Short Term Radiation Therapy (5 × 5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients with Primarily Resectable Pancreatic Cancer - NEOPANC." BMC Cancer 12 (2012). https://doi.org/10.1186/1471-2407-12-112.

MLA (9th ed.) Citation

Röder, Falk, et al. "Clinical Phase I/II Trial to Investigate Neoadjuvant Intensity-modulated Short Term Radiation Therapy (5 × 5 Gy) and Intraoperative Radiation Therapy (15 Gy) in Patients with Primarily Resectable Pancreatic Cancer - NEOPANC." BMC Cancer, vol. 12, 2012, https://doi.org/10.1186/1471-2407-12-112.